|
AU3793400A
|
|
Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
|
|
AU1136000A
|
|
Cyclic peptide analogs of somatostatin
|
|
US6150333A
|
|
Methods of using a somatostatin analogue
|
|
WO0004916A1
|
|
Encapsulation of water soluble peptides
|
|
US6180619B1
|
|
Prenyl transferase inhibitors
|
|
US6004928A
|
|
Method of treating hyperlipidemia
|
|
US5968903A
|
|
Inhibition of H. pylori proliferation
|
|
AU5150798A
|
|
Treatment of bone fracture
|
|
WO9808528A1
|
|
Method of inhibiting fibrosis with a somatostatin agonist
|
|
US6262229B1
|
|
Somatostatin antagonists
|
|
KR20000022304A
|
|
Inhibitors of prenyl transferases
|
|
RU2201931C2
|
|
Inhibitors of farnesyltransferase and methods of inhibition of farnesyltransferase
|
|
ZA9701254B
|
|
Farnesyl transferase inhibitors
|
|
IL141626D0
|
|
Farnesyl transferase inhibitors
|
|
CA2245823A1
|
|
Farnesyl transferase inhibitors
|
|
US5969095A
|
|
Analogs of parathyroid hormone
|
|
ZA9607972B
|
|
Cyclic peptide analogs of somatostatin
|
|
CA2226177A1
|
|
Analogs of parathyroid hormone
|
|
RU2157699C2
|
|
Peptides with affinity for parathyroid hormone and activity- stimulating adenylcyclases
|
|
US5767274A
|
|
Prenyl transferase inhibitors
|
